Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1511 (LINC01511) is a long non-coding RNA (lncRNA) gene transcribed in humans, belonging to the class of intergenic lncRNAs[1][6][5]. LINC01511 is located at chromosome 21q22 and is expressed in various tissues, with distinct upregulation noted in antigen-experienced T cells, suggesting a possible function in immune memory and T cell activity[6]. While its precise biological role is not well established, it is believed to participate in the regulation of transcription and other epigenetic processes, as is typical for lincRNAs[5][7]. Emerging data suggest that LINC01511 may be associated with cancer development and progression, but mechanistic evidence is currently lacking and it is not considered a validated therapeutic target[5]. No known drugs target LINC01511, and there is no recognized use as a biomarker for patient selection or therapy monitoring in clinical settings. Additional research is required to define its full biological significance and clinical relevance[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1511 (LINC01511).